Skip Nav Destination
IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
Cancer Research Communications (2023) 3 (4): 576–591.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Lars van der Veen
- Michael Schmitt
- Marcel A. Deken
- Michael Lahn
International Journal of Toxicology (2023) 42 (6): 515.
- Virender Kumar
- Ram I. Mahato
Cancer Letters (2023) 579: 216462.
